RecruitingNCT03358979

Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)


Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Enrollment

100 participants

Start Date

Dec 14, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Modifications of cell surface markers (including EMMPRIN) were observed in conjunctival epithelial cells during dry eye syndrome ; this study aims to describe the modifications of the repartition of these cell surface markers before and after initiation of a treatment.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Patients:
  • years and over
  • Severe eye dryness (grade 3 or 4) as defined by the International Dry Eye Work Shop (2007): Frequent symptoms, Impregnation of fluorescein at the conjunctival level, marked fluorescein staining at the corneal level, Tear Break Up Time ≤ 5 seconds (fluorescein test) Schirmer's test score without anesthesia ≤ 5mm at 5 minutes
  • Patients without eye treatment or patients undergoing long-term stable eye treatment for whom a new treatment is being introduced
  • \- 18 years and over

Exclusion Criteria4

  • Control subjects:
  • Wearer of contact lenses
  • Topical ocular treatment
  • Known pregnancy or breastfeeding

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fondation Ophtalmologique A de Rothschild

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03358979


Related Trials